Biotechnology company Biovitrum has established a new business
unit, Biovitrum Biopharmaceuticals, to strengthen its position as a
supplier of process development and contract manufacture of
recombinant proteins. The move follows...
Emerson Process Management has won a contract from Celltrion to
automate the first large scale biopharmaceuticals manufacturing
facility in South Korea.
Millipore has reported a hike in third quarter sales and profits on
the back of a revival in the biotechnology industry's fortunes, but
said this may not last to the end of the year.
Chugai says it is building facilities that will give it the largest
bioreactor capacity for biologicals production - at 85,000L - of
any company in the world by 2007.
Cardinal Health is to acquire 100 per cent ownership of protein
production specialist Gala Biotech for $15.5 million (€13.2m)in a
move to bolster its drug development services business.
Crucell has granted a license for its PER.C6 cell line technology
to Novavax, allowing the latter company to start offering contract
manufacturing services for vaccines.
Boehringer Ingelheim doubles its biopharmaceutical production
capacity at a stroke with the completion of a new plant at its site
in Biberach, Germany; a similar expansion in Austria is also
underway.
The axe looks set to fall on Scottish biotechnology company PPL
Therapeutics now that the company put itself up for sale, having
failed to convince investors of a rescue plan.
The notion that there is undercapacity in biomanufacturing has
become common wisdom, but a new study suggest that now supply and
demand are in balance.
An October conference on biogenerics will see research-based
biopharmaceutical companies and their generic rivals battle to win
the hearts and minds of regulators.
The UK's Genetix, which makes gene and protein research equipment,
said it had received orders from leading pharmaceutical groups for
two of its new products.
The organisers of CORDIA EuropaBio 2003 have revealed the keynote
speakers for the 'largest convention in Europe for trade,
investment, partnership and information exchange'.
KBI BioPharma, a start-up biopharma contract manufacturer, has
signed an agreement to buy a facility in North Carolina that could
be online in 6-9 months.
Swedish biotech tools company Cellectricon says it has now received
orders from three of the top five pharmaceutical companies for its
Dynaflow microfluidic chip technology for increasing productivity
in the drug discovery process.
KS Biomedix has confirmed that it is in negotiations that may lead
to a merger and add to the mini-wave of consolidation sweeping over
the UK industry.
Alfa Laval and Millipore are to work together to supply tools for
the recovery of biopharmaceutical proteins generated by cell
culture and fermentation.
Lonza Biotec is to manufacture PEGylated antibody fragment-based
drugs for Celltech under the terms of a new agreement between the
two companies. The two companies have also reached an agreement on
a prior deal relating to Celltech's...
A new range of cell culture vessels developed by Switzerland's
Integra Biosciences promises to increase production yields in
laboratories making monoclonal antibodies and recombinant proteins.
Schroder Ventures Life Sciences has raised $402 million (€344m) for
its biotechnology investment fund, providing a signal that venture
capital may at last be turning its head back in the direction of
the sector.
An international conference serving global centres of excellence
for biotechnology, so-called 'bio-technopoles,' life science parks
and 'bio-incubators' will take place ahead of the 7th European
Biotech Crossroads...
Dutch life sciences company DSM has broken ground on a new site in
Montreal, Canada, set to become a large-scale biopharmaceuticals
plant. Phase one - at a cost of €100m - due for completion by 2005.
Millipore, which specialises in providing technologies, tools and
services for the discovery, development and production of new
therapeutic drugs, has reported first-quarter 2003 sales of $187
million (€173 million), up 13 per cent...
Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...
US outsourcing company Cardinal Health is to provide alternative
drug formulation development and delivery capabilities for the
biotechnology and pharmaceutical industries, the company announced
this week.
Genetronics Biomedical has completed the sale its BTX division to
Harvard Bioscience for $3.7 million. Genetronics Biomedical's
stockholders approved the sale in a meeting on Friday.